PARTHENON THERAPEUTICS
Parthenon Therapeutics is inventing a novel class of anti-cancer therapies that reprogram the tumor microenvironment (TME). The interplay between cancer cells and their surrounding microenvironment is relevant in drug development as manycancers use the TME to build barriers that shield immune system attack. One approach, PRTH-101, breaks these barriers to overcome recalcitrant cancers. Based on research, the company is designing a portfolio of drug candidates to treat the right patients at the right time.
PARTHENON THERAPEUTICS
Social Links:
Industry:
Biotechnology Life Science Therapeutics
Founded:
2019-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.parthenontx.com
Total Employee:
11+
Status:
Active
Total Funding:
65 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Euro Microsoft Exchange Online
Similar Organizations
Axcella
Axcella is a biotechnology company providing therapeutics development solutions.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Trident Bioscience
Trident Bioscience is a biotech company that stays abreast of the latest technological trends in leading protein structure.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Alexandria Venture Investments
Alexandria Venture Investments investment in Series A - Parthenon Therapeutics
Park West Asset Management
Park West Asset Management investment in Series A - Parthenon Therapeutics
Pfizer Venture Investments
Pfizer Venture Investments investment in Series A - Parthenon Therapeutics
Creacion Ventures
Creacion Ventures investment in Series A - Parthenon Therapeutics
Breakout Ventures
Breakout Ventures investment in Series A - Parthenon Therapeutics
Tekla Capital Management
Tekla Capital Management investment in Series A - Parthenon Therapeutics
KdT Ventures
KdT Ventures investment in Series A - Parthenon Therapeutics
Section 32
Section 32 investment in Series A - Parthenon Therapeutics
Northpond Ventures
Northpond Ventures investment in Series A - Parthenon Therapeutics
Taiho Ventures
Taiho Ventures investment in Series A - Parthenon Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2021-12-01 | Parthenon Therapeutics Appoints Tamas Oravecz, Ph.D., as Chief Scientific Officer |
Official Site Inspections
http://www.parthenontx.com Semrush global rank: 2.5 M Semrush visits lastest month: 7.03 K
- Host name: ec2-54-176-110-96.us-west-1.compute.amazonaws.com
- IP address: 54.176.110.96
- Location: San Jose United States
- Latitude: 37.3388
- Longitude: -121.8914
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 95141
